Daniel Albert, MD, MS

M.D. 1962, University of Pennsylvania School of Medicine;
M.S. 1997, University of Wisconsin-Madison;

Clinical Associate in Ophthalmology, Surgeon USPHS 1966-1968, National Institute of Neurological Disease and Blindness, National Institutes of Health; NIH Special Fellow in Ophthalmic Pathology 1968-1969, Armed Forces Institute of Pathology

1962-1963, Hospital of the University of Pennsylvania;

1963-1966, Hospital of the University of Pennsylvania;

Science Careers Blog

My research focuses on ocular tumors, specifically melanoma and retinoblastoma. My work with retinoblastoma utilizes transgenic mouse models of the tumor to investigate the molecular biology of the disease and whether vitamin D analogs produce tumor regression in these animal models. I also study melanoma in a transgenic mouse model. From 1985-2003, I worked with the National Eye Institute's Collaborative Ocular Melanoma Study (COMS) and was the head of the COMS Pathology Center; I remain curator of the specimens collected during the study. My other interests include medical ethics and the history of medicine and ophthalmology.

Surgical removal of an atypical macular epiretinal membrane in neurofibromatosis type 2: clinicopathologic correlation and visual outcome.
October 10, 2012

Adult capillary hemangioma.
August 16, 2012

The JAMA Network Journals: New Names for the Archives Journals.
July 18, 2012

The JAMA Network Journals: New Names for the Archives Journals.
July 10, 2012

Ensuring appropriate expert testimony for cases involving the "shaken baby".
July 5, 2012

The JAMA Network Journals: New Names for the Archives Journals.
July 4, 2012